The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Issuu FDA to Convene Pharmacy Compounding Advisory Committee in July FDA to weigh easing limits on unproven peptides Compounding warning letters to 503A facilities between 2017 and 2021 Journal of the American Pharmacists Association The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law